• HOME>
  • Investor Relations
Japanese
  • IR News
  • News Releases

more

  • May 18, 2018 (PDF/119KB)R&D
    Sumitomo Dainippon Pharma announces the Clinical Data of Investigational Anti-Cancer Agent Alvocidib will be presented at EHA2018
  • May 17, 2018 (PDF/97KB)R&D
    Sumitomo Dainippon Pharma announces the Clinical Data will be presented at ASCO 2018
  • May 11, 2018 (PDF/48KB)Corporate
    Sumitomo Dainippon Pharma announces Changes in Board of Directors, Audit & Supervisory Board and Other Key Positions
  • May 11, 2018 (PDF/545KB)Finances
    Supplementary Financial Data for the Year Ended March 31, 2018
  • May 11, 2018 (PDF/726KB)Finances
    Summary of Consolidated Financial Results for the Year Ended March 31, 2018 [IFRS]

more

IR Calendar

  • Jun. 19, 2018
    198th Annual Shareholders' Meeting
  • Jul. 27, 2018
    1st Quarter of FY2018 financial results announcement (3:30pm JST) (Planned)

more

  • WITH GRADE AAA Corporate Websites 2017 Nikko Investor Relations Co.,Ltd. Ranking in all listed companies in Japan

  • Internet IR Commendation Award2017